Abstract：Objective: To summarize the experience of robotic-assisted laparoscopic resection and to evaluate its value in the operation of adrenal malignancies. Methods: The clinical data of 9 patients with preoperatively diagnosed adrenal malignancy and receiving robotic-assisted laparoscopic surgery between February 2015 and August 2016 were analyzed. Results: All the operations were successfully performed without conversion. Tumors were located on the left side in 6 cases, and on the right side in 3 cases. The average diameter of the tumors was 7.1 cm (ranging from 3.1 to 15.5 cm). There were 4 cases of adrenal cortical carcinoma, 3 cases of malignant pheochromocytoma, and 2 cases of adrenal metastases. The average operative time was 85 (range, 30-210) min. Average estimated blood loss was 270 (range, 50-1 100) mL. Two patients with adrenal cortical carcinoma required intraoperative blood transfusion. Average postoperative hospital stay was 8.5 (range, 5-12) days. All patients were followed up for 3-11 months. One patient with adrenal cortical carcinoma got local recurrence after 6 months, and the rest 8 cases had no signs of tumor recurrence during the follow-up period. Conclusions: Robotic-assisted laparoscopic resection of adrenal malignancies is technically feasible, and the advantages of field of view and flexibility of robotic arms may improve the outcome of surgery. However, long-term follow-up data are needed to confirm the efficacy of tumor control.
管维，杨俊，王少刚. 机器人辅助腹腔镜肾上腺恶性肿瘤切除术经验分享及文献复习[J]. 微创泌尿外科杂志, 2017, 6(1): 39-42.
Guan Wei , Yang Jun , Wang Shaogang. Robotic-assisted laparoscopic resection for adrenal malignancies: experience sharing and literature review. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2017, 6(1): 39-42.
[1]Nieman LK. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab, 2010,95(9):4106-4113. [2]Gagner M, Lacroix A, Bolté E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med, 1992,327(14):1033-1033. [3]Hall DW, Raman JD. Has laparoscopy impacted the indications for adrenalectomy? Curr Urol Rep, 2010,11(2):132-137. [4]Nehs MA, Ruan DT. Minimally invasive adrenal surgery: an update. Curr Opin Endocrinol Diabetes Obes, 2011,18(3):193-197. [5]Duncan JL 3rd, Fuhrman GM, Bolton JS, et al. Laparoscopic adrenalectomy is superior to an open approach to treatprimary hyperaldosteronism. Am Surg, 2000,66(10): 932-935. [6]Lang B, Fu B, OuYang JZ et al. Retrospective comparison ofretroperitoneoscopic versus open adrenalectomy for pheochromocytoma. J Urol, 2008,179(1): 57-60. [7]Hemal AK, Singh A, Gupta NP. Whether adrenal mass more than 5 cm can pose problem in laparoscopic adrenalectomy? An evaluation of 22 patients. World J Urol, 2008,26(5): 505-508. [8]Porpiglia F, Fiori C, Daffara F, et al. Retrospective evaluation of the outcome of open versus laparoscopicadrenalectomy for stage I and II adrenocortical cancer. Eur Urol, 2010,57(5):873-878. [9]Brix D, Allolio B, Fenske W, et al. Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol, 2010,58(4):609-615. [10]Ball MW, Hemal AK, Allaf ME. International Consultation on Urological Diseasesand European Association of Urology International Consultation on MinimallyInvasive Surgery in Urology: laparoscopic and robotic adrenalectomy. BJU Int, 2017,119(1):13-21. [11]Horgan S, Vanuno D. Robots in laparoscopic surgery. J Laparoendosc Adv Surg Tech A, 2001,11(6):415-419. [12]唐露,王保军,李新涛,等.机器人辅助腹腔镜手术与传统后腹腔镜手术治疗肾上腺肿瘤的疗效比较.临床泌尿外科杂志,2016,31(1):5-8. [13]Brandao LF, Autorino R, Laydner H, et al. Robotic versus laparoscopic adrenalectomy: asystematic review and meta-analysis. Eur Urol, 2014,65(6):1154-1161. [14]Yiannakopoulou E. Robotic assisted adrenalectomy: Surgical techniques, feasibility, indications, oncological outcome and safety. Int J Surg, 2016,28:169-172. [15]沈周俊,王先进,许天源.机器人辅助腹腔镜肾上腺手术的医用现状.临床泌尿外科杂志,2015,30(5):381-384.
